Pulmonx (LUNG) Other Non-Current Assets (2020 - 2025)
Pulmonx's (LUNG) quarterly Other Non-Current Assets came in at $258000.0 in Q4 2025, down 77.29% year-on-year from $1.1 million in Q4 2024, and down 82.99% on a QoQ basis from $1.5 million in Q3 2025.
Pulmonx (LUNG) Other Non-Current Assets (2020 - 2025) Analysis & Trends
Pulmonx (LUNG) has 6 years of Other Non-Current Assets data on file, last reported at $258000.0 in Q4 2025.
- On a quarterly basis, Other Non-Current Assets fell 77.29% year-over-year to $258000.0 in Q4 2025; TTM through Dec 2025 was $258000.0, a 77.29% decrease from a year earlier, with the FY2025 full-year figure at $258000.0, down 77.29% from the prior year.
- Other Non-Current Assets for Q4 2025 stood at $258000.0, down from $1.5 million in the prior quarter.
- Over the last five years, Other Non-Current Assets for LUNG reached as high as $1.6 million in Q2 2025 and fell as low as $231000.0 in Q1 2021.
- Historically, Other Non-Current Assets has averaged $471500.0 across 5 years, with a median of $246500.0 in 2023.
- On a YoY basis, Other Non-Current Assets climbed as much as 537.74% in 2025 and fell as far as 77.29% in 2025.
- Year by year, Other Non-Current Assets stood at $731000.0 in 2021, then sank by 68.4% to $231000.0 in 2022, then surged by 155.84% to $591000.0 in 2023, then surged by 92.22% to $1.1 million in 2024, then slumped by 77.29% to $258000.0 in 2025.
- Per Business Quant data, the three most recent Other Non-Current Assets figures were $258000.0 in Q4 2025, $1.5 million in Q3 2025, and $1.6 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.05 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 285.90 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 828.89 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 164.00 Mn |
| 10 | Pulmonx | 49.94 Mn | -19.81 Mn | - | 258,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 258,000.00 |
| Sep 30, 2025 | 1.52 Mn |
| Jun 30, 2025 | 1.64 Mn |
| Mar 31, 2025 | 257,000.00 |
| Dec 31, 2024 | 1.14 Mn |
| Sep 30, 2024 | 258,000.00 |
| Jun 30, 2024 | 257,000.00 |
| Mar 31, 2024 | 236,000.00 |
| Dec 31, 2023 | 591,000.00 |
| Sep 30, 2023 | 236,000.00 |
| Jun 30, 2023 | 466,000.00 |
| Mar 31, 2023 | 231,000.00 |
| Dec 31, 2022 | 231,000.00 |
| Sep 30, 2022 | 231,000.00 |
| Jun 30, 2022 | 231,000.00 |
| Mar 31, 2022 | 231,000.00 |
| Dec 31, 2021 | 731,000.00 |
| Sep 30, 2021 | 231,000.00 |
| Jun 30, 2021 | 231,000.00 |
| Mar 31, 2021 | 231,000.00 |